ESR1 and gastric cancer: A prior study has reported an elevated positivity rate of estrogen receptors (ERs) and tumorigenic mechanism of estrogen in the development of ER-positive diffuse-type GC in young female patients, which may account for the higher incidence of this subtype among younger female GC patients.9